Isoxicam is a monocarboxylic acid amide that is piroxicam in which the pyrid-2-yl group is replaced by a 5-methyl-1,2-oxazol-3-yl group. A non-steroidal anti-inflammatory drug, it was withdrawn from the market in the 1980s following its association with cases of Stevens-Johnson syndrome. Among its listed roles, it functions as a non-steroidal anti-inflammatory drug and an antirheumatic drug. It is a monocarboxylic acid amide, a benzothiazine and a member of isoxazoles. Isoxicam is a non-steroidal anti-inflammatory drug that is not marketed in the United States. Its therapeutic use is listed as analgesics. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Maxicam, Isoxicamum and Isoxicamo. Its PubChem CID is 54677972.
Isoxicam
| CAS No | 34552-84-6 |
|---|---|
| Molecular Formula | C14H13N3O5S |
| Molecular Weight | 335.34 g/mol |
| Synonyms | 4-hydroxy-2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,1-dioxo-1λ6,2-benzothiazine-3-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Isoxicam is a monocarboxylic acid amide that is piroxicam in which the pyrid-2-yl group is replaced by a 5-methyl-1,2-oxazol-3-yl group. A non-steroidal anti-inflammatory drug, it was withdrawn from the market in the 1980s following its association with cases of Stevens-Johnson syndrome.
The listed CAS number is 34552-84-6.
The listed molecular formula is C14H13N3O5S.
The listed molecular weight is 335.34 g/mol.
4-hydroxy-2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,1-dioxo-1λ6,2-benzothiazine-3-carboxamide.
The source lists Maxicam, Isoxicamum and Isoxicamo.